Post-earnings recap
Reported
Tue, May 10, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's earnings report shows a solid EPS performance, exceeding expectations by nearly 8%. The stock reacted positively, rising over 10% in response. The lack of revenue data may leave some investors cautious, but the EPS beat suggests the company is managing its costs effectively.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.65 | N/A | +7.79% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook on their EPS performance. However, they did not provide specific guidance or revenue details.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to improve operational efficiencies.